"Yellow Fever Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.
| Descriptor ID |
D022341
|
| MeSH Number(s) |
D20.215.894.899.970
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Yellow Fever Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Yellow Fever Vaccine".
This graph shows the total number of publications written about "Yellow Fever Vaccine" by people in this website by year, and whether "Yellow Fever Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 2 | 2 | 4 |
| 2002 | 5 | 0 | 5 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 1 | 5 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 0 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Yellow Fever Vaccine" by people in Profiles.
-
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil. Microbiol Spectr. 2024 May 02; 12(5):e0370323.
-
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever. Clin Infect Dis. 2023 08 22; 77(4):565-573.
-
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients. Clin Immunol. 2023 06; 251:109321.
-
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. mBio. 2022 06 28; 13(3):e0051222.
-
Even old foes can learn sweet new tricks. Cell Host Microbe. 2022 02 09; 30(2):151-153.
-
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Lancet. 2021 01 09; 397(10269):119-127.
-
Yellow Fever Remains a Potential Threat to Public Health. Vector Borne Zoonotic Dis. 2016 08; 16(8):566-7.
-
Yellow fever vaccine supply: a possible solution. Lancet. 2016 Apr 16; 387(10028):1599-600.
-
Yellow fever. J Clin Virol. 2015 Mar; 64:160-73.
-
17D Yellow Fever Virus Vaccine. Am J Trop Med Hyg. 2013 Dec; 89(6):1225.